SEARCH

SEARCH BY CITATION

References

  • 1
    Villar J, Carroli G, Wojdyla D, et al. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? Am J Obstet Gynecol 2006;194:92131.
  • 2
    Magee LA. Drugs in pregnancy. Antihypertensives. Best Pract Res Clin Obstet Gynaecol 2001;15:82745.
  • 3
    Duley L, Henderson-Smart DJ, Meher S. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev 2006;3:CD001449.
  • 4
    Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003;102:18192.
  • 5
    Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2009;1:CD002252.
  • 6
    Von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 2000;355:8792.
  • 7
    Dutch Society of Obstetrics and Gynecology. Hypertensieve aandoeningen in de zwangerschap. Guideline version 2.0; 2005.
  • 8
    Ounsted MK, Moar VA, Good FJ, Redman CW. Hypertension during pregnancy with and without specific treatment; the development of the children at the age of four years. Br J Obstet Gynaecol 1980;87:1924.
  • 9
    Cockburn J, Moar VA, Ounsted M, Redman CW. Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet 1982;319:6479.
  • 10
    Lamming GD, Broughton PF, Symonds EM. Comparison of the alpha and beta blocking drug, labetalol, and methyl dopa in the treatment of moderate and severe pregnancy-induced hypertension. Clin Exp Hypertens 1980;2:86595.
  • 11
    Vos PG. Handleiding bij de Bourdon-Vos test, 2nd revised edn. Lisse: Swets & Zeitlinger, 1988.
  • 12
    Bleichroth N, Drenth PJD, Zaal JN, Resing WCM. Handleiding bij de Revisie Amsterdamse Kinder Intelligentie Test. Lisse: Swets & Zeitlinger, 1987.
  • 13
    Visser RSH, van Vliet-Mulder JC, Evers A, Ter Laak J. Documentatie van tests en testresearch in Nederland. Amsterdam: Nederlands Instituut van Psychologen, 1982.
  • 14
    Wiegersma PH. Motorische diagnostiek: evaluatie van lichamelijke vaardigheden bij kinderen. Lisse: Swets & Zeitlinger, 1986.
  • 15
    Verhulst FC, Koot JM, Akkerhuis GW, Veerman JW. Practische handleiding voor de CBCL. Assen: Van Gorcum, 1990.
  • 16
    Abel EL. Behavioral Teratogenesis and Behavioral Mutagenesis: A Primer in Abnormal Development. New York: Plenum, 1989.
  • 17
    Visser GHA, Eilers PHC, Elferink-Stinkens PM, Merkus HMWM, Wit JM. New Dutch reference curves for birthweight by gestational age. Early Hum Dev 2009;85:73744.
  • 18
    Sibai BM, Gonzalez AR, Mabie WC, Moretti M. A comparison of labetalol plus hospitalization versus hospitalization alone in the management of preeclampsia remote from term. Obstet Gynecol 1987;70:3237.
  • 19
    Lundgren EM, Tuvemo T. Effects of being born small for gestational age on long-term intellectual performance. Best Pract Res Clin Endocrinol Metab 2008;22:47788.
  • 20
    Lahti J, Räikkönen K, Kajantie E, et al. Small body size at birth and behavioural symptoms of ADHD in children aged five to six years. J Child Psychol Psychiatry 2006;47:116774.
  • 21
    Rogers RC, Sibai BM, Whybrew WD. Labetalol pharmacokinetics in pregnancy-induced hypertension. Am J Obstet Gynecol 1990;162:3626.
  • 22
    Harper A, Murnaghan GA. Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol. Br J Obstet Gynaecol 1991;98:4539.
  • 23
    Rey E. Effects of methyldopa on umbilical and placental artery blood flow velocity waveforms. Obstet Gynecol 1992;80:7837.
  • 24
    Mahmoud TZ, Bjornsson S, Calder AA. Labetalol therapy in pregnancy induced hypertension: the effects on fetoplacental circulation and fetal outcome. Eur J Obstet Gynecol Reprod Biol 1993;50:10913.
  • 25
    Montan S, Anandakumar C, Arulkumaran S, Ingemarsson I, Ratnam SS. Effects of methyldopa on uteroplacental and fetal hemodynamics in pregnancy-induced hypertension. Am J Obstet Gynecol 1993;168:1526.
  • 26
    Magee LA, Ornstein MP, von Dadelszen P. Fortnightly review: management of hypertension in pregnancy. BMJ 1999;318:13326.
  • 27
    Shimohira M, Kohyama J, Kawano Y, Suzuki H, Ogiso M, Iwakawa Y. Effect of alpha-methyldopa administration during pregnancy on the development of a child’s sleep. Brain Dev 1986;8:41623.
  • 28
    Jones HMR, Cummings AJ. A study of the transfer of alpha-methyldopa to the human foetus and newborn infant. Br J Clin Pharmacol 1978;6:4324.
  • 29
    Boer GJ, Feenstra MG, Erdtsieck-Ernste BH, Gorter JA, Mirmiran M. Lasting effects of early noradrenergic receptor occupation on brain noradrenaline turnover and on beta-receptors. Dev Pharmacol Ther 1990;15:22433.
  • 30
    Huisjes HJ, Hadders-Algra M, Touwen BC. Is clonidine a behavioural teratogen in the human? Early Hum Dev 1986;14:438.
  • 31
    Smedje H, Broman J-E, Hetta J. Associations between disturbed sleep and behavioural difficulties in 635 children aged six to eight years: a study based on parents’ perceptions. Eur Child Adolesc Psychiatry 2001;10:19.